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Manipulation of Cellular Processing Bodies
and Their Constituents by Viruses
Asit K. Pattnaik and Phat X. Dinh
The processing bodies (PBs) are a form of cytoplasmic aggregates that house the cellular RNA decay machinery
as well as many RNA-binding proteins and mRNAs. The PBs are constitutively present in eukaryotic cells and
are involved in maintaining cellular homeostasis by regulating RNA metabolism, cell signaling, and survival.
Virus infections result in modification of the PBs and their constituents. Many viruses induce compositionally
altered PBs, while many others use specific components of the PBs for their replication. PB constituents are also
known to restrict virus replication by a variety of mechanisms. Further, continuing studies in this rapidly
emerging field of PB-virus interactions will undoubtedly provide important clues to the understanding of the
role of PBs in cellular homeostasis as well as their role in virus infections and innate immune signaling.
Introduction
Eukaryotic cells respond to virus infections or stressconditions by limiting or arresting cellular and viral pro-
tein translation through degradation of viral and cellular
mRNAs, as well as by sequestering mRNAs and translation
initiation factors in cytoplasmic RNP granules. Two such RNP
granules, the stress granules (SGs), and the processing bodies
(PBs, also known as GWbodies) (Eystathioy et al., 2003; Eulalio
et al., 2007) have been well-characterized in the recent years.
Both SGs and PBs are electron-dense, nonmembranous, and
highly dynamic structures that constantly exchange RNAs and
proteins with the cytoplasm, while specific marker proteins
also remain static within these granules (Buchan and Parker,
2009). Over 100 mammalian genes have been identified for SG
assembly, nearly 40 genes for PB assembly, and over 30 genes
for coordinate SG and PB assembly (Ohn et al., 2008). Me-
chanistically, the molecular events leading to the assembly of
SGs and PBs are poorly understood but it is thought that the PB
formation involves aggregation of RNA-binding proteins and
mRNAs in the cytosol (Franks and Lykke-Andersen, 2008).
Since these granules are nonmembranous, it is intriguing to
conceptualize their nucleation, assembly and maintenance
without liquid (matrix) mixing with the cytosol. However,
recent studies suggest a unifying principle of compartmen-
talization without membranes in which a concentration-
dependent liquid-liquid unmixing of mRNAs and proteins
with low complexity sequence domains (regions with low
amino acid diversity) may drive assembly of such gran-
ules (Kato et al., 2012). Signaling through the dual specificity
tyrosine-phosphorylation-regulated kinase 3 (DYRK3) and the
mechanistic target of rapamycin C1 (mTORC1) is required for
the assembly of these granules (Wippich et al., 2013).
The PBs are constitutively present in the cytoplasm of cells
under physiological conditions (Kulkarni et al., 2010) and
their number and size increase upon translational arrest
(Teixeira et al., 2005). The PBs are involved in sequestration,
storage, and/or degradation of mRNAs (Brengues et al.,
2005; Kulkarni et al., 2010). Constituents of PBs include
proteins that function in general mRNA degradation path-
ways, such as XrnI, Dcp1-2, Lsm1-7, Lsm16 (Edc3), Rap55
(Lsm14A), Ge1 (Hedls, Edc4), PatL1, DDX6; proteins
involved in nonsense-mediated mRNA decay (NMD)
pathway; translational repressors, such as eIF4E-T, CPEB1,
Lsm14A, PatL1, and DDX6; and components of the
RNAi pathway, including Ago1-4, GW182, Dicer, miRNAs
(Ernoult-Lange et al., 2012). The PBs and SGs share many
mRNAs and proteins (described here as PB-SG markers)
such as Ago1-4, APOBEC, BRF1, DDX3/6, eIF4E, FAST
Lin28, Mex3b, PCBP1-2, Rap55, TTP, Upf1, Xrn1; however,
proteins, such as Ccr4, Dcp1-2, Edc1-3, eIF4E-T, GW182, Ge1,
Lsm1-7, Mex3a, PatL1, Pan2, Pop2 (described here as PB
markers) are only found in the PBs (Buchan and Parker,
2009) (Fig. 1). It has been suggested that the PBs are the
nucleation sites for SG formation (Kedersha et al., 2005).
Alteration of PBs by Virus Replication
Although a significant body of information is available on
how viruses influence the SGs and their constituents, less is
known about the viral manipulation of the PBs and their con-
stituents. Interestingly, the majority of the viruses currently
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known to influence PBs are the RNAviruses,most ofwhich are
positive-stranded.
Recent studies have revealed that HCV replication leads to
dispersion or alteration of PBs in cells, while virus-receptor
interactions or viral protein expression have no discernible
effect (Ariumi et al., 2011; Perez-Vilaro et al., 2012; Pager et al.,
2013). Interestingly, not all PBs were disrupted by HCV
replication (Perez-Vilaro et al., 2012; Pager et al., 2013) and
the number of PBs as examined by the use of PB markers
Dcp1 or GW182 were similar to those in uninfected cells
(Perez-Vilaro et al., 2012), indicating that HCV replication
alters PB composition (Perez-Vilaro et al., 2012; Pager et al.,
2013). Similarly, in cells infected with West Nile virus (WNV)
and Dengue virus, PBs are disrupted and their number de-
clines due primarily to the recruitment of many of the PB
constituents (LSm1, GW182, DDX3/6, Xrn1) to the sites of
viral replication (Emara and Brinton, 2007; Chahar et al.,
2012). Disruption of PBs is also seen in cells infected with
poliovirus and Coxsackievirus B3 as a result of degradation
of Pan3, Xrn1, and Dcp1 (Dougherty et al., 2011), although
other PB markers (DDX6, GW182, Edc3) were not degraded.
It appears that degradation of some PB markers in these
picornavirus-infected cells may be sufficient to disrupt PBs.
However, use of multiple PB markers would be necessary
for a clear understanding of the role of PBs in these virus-
infected cells.
Among the negative-strand RNA viruses, the influenza
virus NS1 protein suppresses formation of PBs (Mok et al.,
2012) through interaction with Rap55, a PB constituent. This
interaction is thought to be necessary for efficient viral rep-
lication through blocking the sequestration of the viral NP
and the NP-associated RNAs in PBs. The PBs also appears to
play important role(s) in supporting Hantanvirus transcrip-
tion by sequestering nucleocapsid protein-bound cellular
mRNAs containing 5¢-caps (Mir et al., 2008). In vesicular
stomatitis virus (VSV) infected cells, viral P protein interacts
and colocalizes with PB-SG markers, PCBP1/2 (Dinh et al.,
2011). Although PB formation appears to be unaffected by
VSV infection (Dinh et al., 2013), further work with addi-
tional PB-specific markers would be necessary.
Less is evident about how DNA viruses affect PBs in in-
fected cells. The number of PBs is reduced in adenovirus-
infected cells as the viral E4 11K protein, through its specific
interaction with DDX6, mediates redistribution of several PB
FIG. 1. Interaction of viruses with PBs and its constituents. Cellular proteins (in rectangular box on the left side) aggregate
to form PB (shown as a circle) with PB markers in blue and PB-SG markers in red. Shown are viruses that use various PB
constituents to support their replication, while other viruses are inhibited by various components. HCV, WNV, DeV, Polio,
and CVB3 virus infection cause redistribution of PB markers to viral replication sites near lipid droplet (yellow circles) around
the ER. Some viruses inhibit aggregation of proteins (identified along the lines) into PB. Many individual PB and PB-SG
components (identified with outlines within the circle) have been found to support or antagonize virus replication. SG, stress
granule; PBs, processing bodies; HIV-1, human immunodeficiency virus 1; HBV, hepatitis B virus; PFV1, prototype foamy
virus 1; TMV, tobacco mosaic virus; TBSV, tomato bushy stunt virus; CPV, cricket paralysis virus; WSSV, white spot
syndrome virus; TCV, turnip crinkle virus; HCMV, human cytomegalovirus; DeV, dengue virus; WNV, West Nile virus;
HTLV, human T-lymphotropic virus; L-A, yeast L-A double-stranded RNA virus; 20S RNA, 20S RNA narnavirus; YFV,
yellow fever virus; Ty1, Ty1 retrotransposon; Ad5, adenovirus 5; BMV, brome mosaic virus; HSV-1, herpes simplex virus 1;
HCV, hepatitis C virus; CVB3, Coxsackie virus B3; ER, endoplasmic reticulum; N, nucleus.
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components to aggresomes (Greer et al., 2011) (Fig. 1), the
sites for inactivation or degradation of cellular misfolded/
unwanted proteins (Kopito, 2000).
Thus, it appears that individual viruses manipulate and
modify the PBs and their constituents by disparate mecha-
nisms; however, the precise role(s) of the PBs in viral life cycle
remains unclear. This is primarily due to the fact that (1)
majority of these studies use PB-SG markers but draw specific
conclusions only for PBs; (2) in many cases, the number of PB
markers used is limited, especially when a PB protein is si-
lenced, PB formation by that specific protein was examined,
while PB formation by other authentic PB markers was not
analyzed; and (3) in several studies, the role of PB markers
hijacked by viruses was not investigated simultaneously with
the disruption of PB. These experimental shortcomings have
restricted unequivocal interpretation of the role of the PBs
and/or their constituents in virus infections.
PB Constituents That Support Virus Replication
Among the PB components translocating to HCV repli-
cation sites around lipid droplets, DDX6, Ago2, Lsm1, PatL1,
Ge1, and miR122 were found to be required for HCV repli-
cation as their knockdown negatively affected viral RNA
replication and virus growth (Ariumi et al., 2011; Berezhna
et al., 2011; Pager et al., 2013; Thibault et al., 2013). In contrast,
knockdown of Rap55, another PB-associated marker, re-
sulted in reduced PBs in the cells, but had no adverse effect
on HCV replication or virus production (Perez-Vilaro et al.,
2012). HCV replication supporting structures formed around
lipid droplets that contain hijacked PB markers appear to be
distinct from the canonical PBs, suggesting that HCV repli-
cation induces the formation of compositionally altered PBs
(Berezhna et al., 2011; Perez-Vilaro et al., 2012). It appears that
HCV selectively takes advantage of several factors belong-
ing to PB-RNAi pathway (Ago2, GW182, miR122) and PB-
mRNA decay pathway (LSm1, GW182, DDX6, Ge1, Xrn1) for
replication, while other PB components, such as Rap55,
Dcp1-2 do not seem to influence HCV replication. Mechan-
istically, how the PB constituents that translocate to lipid
droplets are involved for HCV replication is not known at
this time but a protective role of miR122 in antagonizing the
exonuclease activity of Xrn1 in HCV RNA degradation has
been recently demonstrated (Li et al., 2013).
As shown in Figure 1, PB constituents support replication
of many viruses in mammalian cells. PB constituents are also
required for virus infections in yeast. Using Saccharomyces
cerevisiae, Dhh1 (DDX6 homolog), Kem1 (Xrn1 homolog),
LSm1, and Pat1 (PatL1 homolog) were shown to support
assembly of retrotransposition-competent virus-like particles
of Ty1 (Checkley et al., 2010). Brome mosaic virus (BMV)
infection increases the number and size of PB foci (Beckham
et al., 2007) and it has been shown that BMV replication and
protein expression in yeast requires LSm1-7, Dhh1, and Pat1.
LSm1 interacts and colocalizes with viral RdRp and RNA.
LSm1-7 binds to a tRNA-like structure at the 3¢-untranslated
region and two internal A-rich single-stranded regions in the
BMV genome to regulate viral replication and translation
(Galao et al., 2010).
Utilization of PB components by DNA viruses is less well
characterized. HSV-1 Us11 protein was shown to interact with
PatL1, a cellular kinesin light-chain-related protein (Benboud-
jema et al., 2003). This interaction is presumed to be important
for the intracellular movement of viral components. Hepatitis
B virus (HBV), core (HBc), and surface (HBs) proteins but not
HBx protein interact and colocalize with Ago2 in the ER and
other subcellular compartments, while Ago2 appears to play a
role in HBV life cycle (Hayes et al., 2012). The Kaposi’s sar-
coma-associated herpesvirus SOX protein induces internal
cleavage of host mRNA, which are then degraded by the 5¢-3¢
cellular exonuclease Xrn1 (Covarrubias et al., 2011).
These studies shed light into our understanding of how
viruses exploit PB proteins to enhance their replication.
Many components of the cellular RNAi pathway as well as
miRNAs are localized into PBs and it seems that in addition
to its putative roles in suppression of virus infection (Ar-
buthnot, 2010), multiple PB-RNAi proteins are utilized by
both RNA and DNA viruses for their replication, assembly
and budding.
PB Constituents That Suppress Virus Replication
PB constituents are also known to suppress replication of
many viruses (Fig. 1). Prominent among these are certain
members of APOBEC3 (apolipoprotein B mRNA editing
enzyme catalytic polypeptide like 3) family, which are in-
corporated into PBs and encode cytidine deaminase activity
to mutate cytidine residues into uridines in nascent minus
strand of retroviral reverse transcripts leading to G to A
hyper-mutation in the plus-strand of viral DNA and com-
promise virus replication (Harris et al., 2003; Bishop et al.,
2004). Among the seven members in APOBEC3 family, four
have been shown to antagonize HIV-1 (Martin et al., 2011;
Imahashi et al., 2012). APOBEC3F and 3G localize to PBs as
well as SGs (Wichroski et al., 2006; Gallois-Montbrun et al.,
2007) where they interact with different proteins, including
the RISC protein (Ago2), PB proteins, (Dcp1 and Dcp2) and
PB-SG protein (DDX6) (Kozak et al., 2006). Although dis-
crepancies exist with regard to interactions among various
PB constituents and HIV-1 RNA, mRNA, and Gag proteins
(Nathans et al., 2009; Yu et al., 2011; Bouttier et al., 2012;
Phalora et al., 2012; Reed et al., 2012), the majority of the
studies show that many PB components suppress HIV-1
replication by multiple mechanisms. Similar to APOBEC3,
Mov10, an RNA helicase, is incorporated into HIV-1 parti-
cles. Mov10 associates with APOBEC3, localizes to PB as a
partner of Ago2 in RNAi pathway (Meister et al., 2005) and
inhibits HIV-1 replication (Burdick et al., 2010).
Viral Countermeasures for PB Constituents
The antagonistic properties of APOBEC3 proteins on HIV-
1 replication are countered by the viral vif protein (Imahashi
et al., 2012), which degrades APOBEC3 proteins. In human T-
lymphotropic virus type 1 infection, viral tax protein inhibits
NMD pathway via upregulation of Upf1 phosphorylation
and accumulation of phospho-Upf1 in PBs, leading to sta-
bilization of viral and cellular mRNAs to support virus in-
fection (Mocquet et al., 2012). Another PB constituent that is
targeted by a viral component is Xrn1, the 5¢-3¢ exonuclease,
which degrades decapped mRNAs ( Jones et al., 2012).
Genomic RNAs of positive stranded and double stranded
RNA viruses serve directly as mRNA for translation and
their stability is regulated by Xrn1 (and its homologs) as
demonstrated for HCV, Tombusvirus, and L-A virus
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(Esteban et al., 2008; Jaag and Nagy, 2009; Li et al., 2013). In
contrast, Xrn1-mediated mRNA cleavage is not allowed to
complete the degradation of viral genome RNA in cells in-
fected with Flaviviruses (including WNV, Dengue, Kunjin,
and Yellow fever virus) (Funk et al., 2010; Silva et al., 2010;
Moon et al., 2012) due to the presence of secondary and
tertiary structures at the 3¢-UTR of the viral genomes, re-
sulting in the production of short subgenomic flavivirus
RNA (sfRNA), which is required for viral infections (Moon
et al., 2012) and pathogenesis in mice (Silva et al., 2010). These
studies indicate that sfRNA attenuates Xrn1 activity to allow
virus replication to continue unabated. In contrast, Polio-
virus selectively degrades Xrn1, a step presumed to be pre-
requisite for subsequent disruption of PB in infected cells
(Dougherty et al., 2011).
Concluding Remarks
The consequences of viral interactions with cellular PBs
and their constituents appear to be multifold. While some are
beneficial, other interactions negatively affect virus replica-
tion, and therefore, viruses have evolved mechanisms to
counter the PBs and their components. As the field of PB-
virus interactions is growing rapidly, mechanistic under-
standing of how different viruses manipulate PBs and their
constituents will likely emerge. The current knowledge of the
role of PBs in virus infections is less complete primarily due
to lack of studies using multiple PB-specific markers in
infected cells. Thus, the real role(s) played by PBs in virus
infections remain elusive. Additionally, how virus infections
and subsequent cellular signaling events lead to increase in
size and number of PBs in cells is poorly understood. Since
PBs are intracellular granules constitutively present in nor-
mal cells and play key roles in RNA metabolism, studies
examining how viruses modulate DYRK3-mTORC1 signal-
ing in granule formation and dissolution may provide a
better understanding of the form and function of this in-
triguing organelle in cell biology as well as in virus-host
interactions. Recent identification of Rap55, a PB-associated
protein, as a sensor of viral nucleic acids that activates an-
tiviral responses in early stages of viral infections (Li et al.,
2012) suggests that PBs and their constituents are not only
important maintaining cellular homeostasis by regulating
RNA metabolism, cell signaling, and survival but they may
also play key roles in innate immune signaling.
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